Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model

BACKGROUND: The endocannabinoids system (ECs) mediated mainly by CB1 and CB2 receptors plays an important role in non-alcoholic fatty liver disease by regulating lipid metabolism. This study is to further investigate the expression of CB1 and CB2 in the fat accumulation liver cells and to identify p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Lipids Health Dis
Main Authors: Shi, Dongmei, zhan, Xi, Yu, Xiaofeng, Jia, Minglei, Zhang, Ying, Yao, Jianfeng, Hu, Xiaona, Bao, Zhijun
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4247673/
https://ncbi.nlm.nih.gov/pubmed/25406988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-13-173
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki